Genetics and molecular epidemiology of multiple myeloma: The rationale for the IMMEnSE consortium (Review)

  • Authors:
    • Alessandro Martino
    • Juan Sainz
    • Gabriele Buda
    • Krzysztof Jamroziak
    • Rui Manuel Reis
    • Ramón García-Sanz
    • Manuel Jurado
    • Rafael Ríos
    • Zofia Szemraj-Rogucka
    • Herlander Marques
    • Fabienne Lesueur
    • Victor Moreno
    • Enrico Orciuolo
    • Federica Gemignani
    • Stefano Landi
    • Anna Maria Rossi
    • Charles Dumontet
    • Mario Petrini
    • Daniele Campa
    • Federico Canzian
  • View Affiliations

  • Published online on: December 6, 2011     https://doi.org/10.3892/ijo.2011.1284
  • Pages: 625-638
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

There is strong evidence suggesting the presence of a genetic component in the aetiology of multiple myeloma (MM). However no genetic risk factors have been unequivocally established so far. To further our understanding of the genetic determinants of MM risk, a promising strategy is to collect a large set of patients in a consortium, as successfully done for other cancers. In this article, we review the main findings in the genetic susceptibility and pharmacogenetics of MM and present the strategy of the IMMEnSE (International Multiple Myeloma rESEarch) consortium in contributing to determine the role of genetic variation in pharmacogenetics and in MM risk.

Related Articles

Journal Cover

March 2012
Volume 40 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Martino A, Sainz J, Buda G, Jamroziak K, Reis RM, García-Sanz R, Jurado M, Ríos R, Szemraj-Rogucka Z, Marques H, Marques H, et al: Genetics and molecular epidemiology of multiple myeloma: The rationale for the IMMEnSE consortium (Review). Int J Oncol 40: 625-638, 2012
APA
Martino, A., Sainz, J., Buda, G., Jamroziak, K., Reis, R.M., García-Sanz, R. ... Canzian, F. (2012). Genetics and molecular epidemiology of multiple myeloma: The rationale for the IMMEnSE consortium (Review). International Journal of Oncology, 40, 625-638. https://doi.org/10.3892/ijo.2011.1284
MLA
Martino, A., Sainz, J., Buda, G., Jamroziak, K., Reis, R. M., García-Sanz, R., Jurado, M., Ríos, R., Szemraj-Rogucka, Z., Marques, H., Lesueur, F., Moreno, V., Orciuolo, E., Gemignani, F., Landi, S., Rossi, A. M., Dumontet, C., Petrini, M., Campa, D., Canzian, F."Genetics and molecular epidemiology of multiple myeloma: The rationale for the IMMEnSE consortium (Review)". International Journal of Oncology 40.3 (2012): 625-638.
Chicago
Martino, A., Sainz, J., Buda, G., Jamroziak, K., Reis, R. M., García-Sanz, R., Jurado, M., Ríos, R., Szemraj-Rogucka, Z., Marques, H., Lesueur, F., Moreno, V., Orciuolo, E., Gemignani, F., Landi, S., Rossi, A. M., Dumontet, C., Petrini, M., Campa, D., Canzian, F."Genetics and molecular epidemiology of multiple myeloma: The rationale for the IMMEnSE consortium (Review)". International Journal of Oncology 40, no. 3 (2012): 625-638. https://doi.org/10.3892/ijo.2011.1284